Benitec Biopharma Inc. (BNTC) Revenue History
Annual and quarterly revenue from 2013 to present
BNTC Revenue Over Time (2013–2025)
BNTC Revenue Growth History
5 of 11 years with positive growth- FY2013 revenue growth
- N/A
- FY2014 revenue growth
- +89.5%
- FY2015 revenue growth
- -34.1%
- FY2016 revenue growth
- -59.0%
- FY2017 revenue growth
- -24.2%
- FY2018 revenue growth
- +4.3%
- FY2019 revenue growth
- +3850.6%
- FY2020 revenue growth
- -98.8%
- FY2021 revenue growth
- -39.2%
- FY2022 revenue growth
- +23.7%
- FY2023 revenue growth
- +2.7%
- FY2024 revenue growth
- -100.0%
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $0 | — |
| Q2 2026 | $0 | — |
| Q1 2026 | $0 | — |
| Q4 2025 | $0 | — |
| Q3 2025 | $0 | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | -100.0% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2023)
BNTC's revenue distribution by segment and geography for fiscal year 2023
By Product/Segment
By Geography
BNTC Revenue Analysis (2013–2025)
Current Revenue & Growth
As of June 23, 2026, Benitec Biopharma Inc. (BNTC) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2026) recorded $0 in revenue
Historical Growth Trajectory
BNTC's historical revenue data shows various trends over time. Benitec Biopharma Inc.'s highest annual revenue of $8.1 million was recorded in 2019.
Revenue by Segment
BNTC's revenue is primarily driven by License (100%). With over half of revenue concentrated in License, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including KRYS (+25.1% YoY), QURE (-10.4% YoY), and DTIL (-11.9% YoY). Compare BNTC vs KRYS →
BNTC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BNTCCurrent | $0 | - | - | - | |
 KRYS | $389M | +25.1% | - | 41.5% | |
 QURE | $16M | -10.4% | -15.6% | -1166.8% | |
 DTIL | $34M | -11.9% | +7.1% | -152.2% |
BNTC Historical Revenue Data (2013–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-41,765,000 | - |
| 2024 | $0 | -100.0% | $0 | - | $-22,490,000 | - |
| 2023 | $75K | +2.7% | $75K | 100.0% | $-19,081,000 | -25441.3% |
| 2022 | $73K | +23.7% | $64K | 87.7% | $-17,854,000 | -24457.5% |
| 2021 | $59K | -39.2% | $-64,000 | -108.5% | $-13,596,000 | -23044.1% |
| 2020 | $97K | -98.8% | $282K | 290.7% | $-8,281,000 | -8537.1% |
| 2019 | $8.1M | +3850.6% | $7.8M | 96.2% | $1.8M | 22.4% |
| 2018 | $204K | +4.3% | $-39,472 | -19.3% | $-6,425,921 | -3143.9% |
| 2017 | $196K | -24.2% | $36K | 18.3% | $-12,189,532 | -6222.9% |
| 2016 | $259K | -59.0% | $181K | 70.0% | $-18,624,349 | -7204.2% |
| 2015 | $631K | -34.1% | $607K | 96.3% | $-10,135,958 | -1607.6% |
| 2014 | $956K | +89.5% | $921K | 96.3% | $-13,528,382 | -1414.9% |
| 2013 | $504K | - | $342K | 67.7% | $-7,540,847 | -1494.9% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
13+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BNTC — Frequently Asked Questions
Quick answers to the most common questions about buying BNTC stock.
Is BNTC's revenue growth accelerating or slowing?
BNTC TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is BNTC's revenue history from 2013 to 2026?
Benitec Biopharma Inc. (BNTC) revenue history spans 2013 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is BNTC's long-term revenue growth rate (CAGR)?
Benitec Biopharma Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for BNTC.
Why does BNTC's quarterly revenue fluctuate?
BNTC quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Benitec Biopharma Inc.'s revenue data from 2013 to 2026 shows full historical quarterly detail on this page.
How is BNTC's revenue distributed by segment?
BNTC reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does BNTC's revenue compare to industry peers?
Benitec Biopharma Inc. (BNTC) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.